Similar articles

• DES in saphenous bypass grafts: A treatment in vain?

  Hillegass WB. Hillegass WB. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):21-2. doi: 10.1002/ccd.21649. Catheter Cardiovasc Interv. 2008. PMID: 18561144 No abstract available.
• Late outcomes of drug-eluting versus bare metal stents in saphenous vein grafts: Propensity score analysis.

  Applegate RJ, Sacrinty M, Kutcher M, Santos R, Gandhi S, Little W. Applegate RJ, et al. Catheter Cardiovasc Interv. 2008 Jul 1;72(1):7-12. doi: 10.1002/ccd.21566. Catheter Cardiovasc Interv. 2008. PMID: 18412239
• Should bare metal or drug-eluting stents be used during PCI of saphenous vein graft lesions: waiting for Godot?

  Brilakis ES, Berger PB. Brilakis ES, et al. Catheter Cardiovasc Interv. 2008 Nov 15;72(6):815-8. doi: 10.1002/ccd.21657. Catheter Cardiovasc Interv. 2008. PMID: 19006238 No abstract available.
• Approach to the patient with prior bypass surgery.

  Nguyen T, Pham L, Cheem TH, Douglas JS, Hermiller J, Grines C. Nguyen T, et al. J Interv Cardiol. 2004 Oct;17(5):339-46. doi: 10.1111/j.1540-8183.2004.04033.x. J Interv Cardiol. 2004. PMID: 15491339 Review. No abstract available.
• Percutaneous approaches to recurrent myocardial ischemia in patients with prior surgical revascularization.

  Douglas JS Jr. Douglas JS Jr. Semin Thorac Cardiovasc Surg. 1994 Apr;6(2):98-108. Semin Thorac Cardiovasc Surg. 1994. PMID: 8025144 Review. No abstract available.